Click for best price
Recombinant Activated Coagulation Factor VII Market Size, Share 2023
Coagulation Factor VIIa, recombinant is a coagulation factor indicated for: Treatment of bleeding episodes and perioperative management in adults and children with hemophilia A or B with inhibitors, congenital Factor VII (FVII) deficiency, and Glanzmann?s thrombasthenia with refractoriness to platelet transfusions, with or without antibodies to platelets
This report contains market size and forecasts of Recombinant Activated Coagulation Factor VII in global, including the following market information:
Global Recombinant Activated Coagulation Factor VII Market Revenue, 2018-2023, 2023-2030, ($ millions)
Global Recombinant Activated Coagulation Factor VII Market Sales, 2018-2023, 2023-2030, (Units)
Global top five Recombinant Activated Coagulation Factor VII companies in 2022 (%)
The global Recombinant Activated Coagulation Factor VII market was valued at million in 2022 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period 2023-2030.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million by 2030.
Vial Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Recombinant Activated Coagulation Factor VII include Novo Nordisk, LFB SA HEMA Biologics and AryoGen Pharmed, etc. In 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Recombinant Activated Coagulation Factor VII manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Recombinant Activated Coagulation Factor VII Market, by Type, 2018-2023, 2023-2030 ($ Millions) & (Units)
Global Recombinant Activated Coagulation Factor VII Market Segment Percentages, by Type, 2022 (%)
Vial
Prefilled Syringe
Global Recombinant Activated Coagulation Factor VII Market, by Application, 2018-2023, 2023-2030 ($ Millions) & (Units)
Global Recombinant Activated Coagulation Factor VII Market Segment Percentages, by Application, 2022 (%)
Hemophilia A
Hemophilia B
Other
Global Recombinant Activated Coagulation Factor VII Market, By Region and Country, 2018-2023, 2023-2030 ($ Millions) & (Units)
Global Recombinant Activated Coagulation Factor VII Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Recombinant Activated Coagulation Factor VII revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Recombinant Activated Coagulation Factor VII revenues share in global market, 2022 (%)
Key companies Recombinant Activated Coagulation Factor VII sales in global market, 2018-2023 (Estimated), (Units)
Key companies Recombinant Activated Coagulation Factor VII sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Novo Nordisk
LFB SA HEMA Biologics
AryoGen Pharmed
| Report Attributes |
Report Details |
| Report Title |
Recombinant Activated Coagulation Factor VII Market, Global Outlook and Forecast 2023-2030 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
78 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Recombinant Activated Coagulation Factor VII Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Recombinant Activated Coagulation Factor VII Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Recombinant Activated Coagulation Factor VII Overall Market Size
2.1 Global Recombinant Activated Coagulation Factor VII Market Size: 2022 VS 2030
2.2 Global Recombinant Activated Coagulation Factor VII Revenue, Prospects & Forecasts: 2018-2030
2.3 Global Recombinant Activated Coagulation Factor VII Sales: 2018-2030
3 Company Landscape
3.1 Top Recombinant Activated Coagulation Factor VII Players in Global Market
3.2 Top Global Recombinant Activated Coagulation Factor VII Companies Ranked by Revenue
3.3 Global Recombinant Activated Coagulation Factor VII Revenue by Companies
3.4 Global Recombinant Activated Coagulation Factor VII Sales by Companies
3.5 Global Recombinant Activated Coagulation Factor VII Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Recombinant Activated Coagulation Factor VII Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Recombinant Activated Coagulation Factor VII Product Type
3.8 Tier 1, Tier 2 and Tier 3 Recombinant Activated Coagulation Factor VII Players in Global Market
3.8.1 List of Global Tier 1 Recombinant Activated Coagulation Factor VII Companies
3.8.2 List of Global Tier 2 and Tier 3 Recombinant Activated Coagulation Factor VII Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Recombinant Activated Coagulation Factor VII Market Size Markets, 2022 & 2030
4.1.2 Vial
4.1.3 Prefilled Syringe
4.2 By Type - Global Recombinant Activated Coagulation Factor VII Revenue & Forecasts
4.2.1 By Type - Global Recombinant Activated Coagulation Factor VII Revenue, 2018-2023
4.2.2 By Type - Global Recombinant Activated Coagulation Factor VII Revenue, 2023-2030
4.2.3 By Type - Global Recombinant Activated Coagulation Factor VII Revenue Market Share, 2018-2030
4.3 By Type - Global Recombinant Activated Coagulation Factor VII Sales & Forecasts
4.3.1 By Type - Global Recombinant Activated Coagulation Factor VII Sales, 2018-2023
4.3.2 By Type - Global Recombinant Activated Coagulation Factor VII Sales, 2023-2030
4.3.3 By Type - Global Recombinant Activated Coagulation Factor VII Sales Market Share, 2018-2030
4.4 By Type - Global Recombinant Activated Coagulation Factor VII Price (Manufacturers Selling Prices), 2018-2030
5 Sights By Application
5.1 Overview
5.1.1 By Application - Global Recombinant Activated Coagulation Factor VII Market Size, 2022 & 2030
5.1.2 Hemophilia A
5.1.3 Hemophilia B
5.1.4 Other
5.2 By Application - Global Recombinant Activated Coagulation Factor VII Revenue & Forecasts
5.2.1 By Application - Global Recombinant Activated Coagulation Factor VII Revenue, 2018-2023
5.2.2 By Application - Global Recombinant Activated Coagulation Factor VII Revenue, 2023-2030
5.2.3 By Application - Global Recombinant Activated Coagulation Factor VII Revenue Market Share, 2018-2030
5.3 By Application - Global Recombinant Activated Coagulation Factor VII Sales & Forecasts
5.3.1 By Application - Global Recombinant Activated Coagulation Factor VII Sales, 2018-2023
5.3.2 By Application - Global Recombinant Activated Coagulation Factor VII Sales, 2023-2030
5.3.3 By Application - Global Recombinant Activated Coagulation Factor VII Sales Market Share, 2018-2030
5.4 By Application - Global Recombinant Activated Coagulation Factor VII Price (Manufacturers Selling Prices), 2018-2030
6 Sights by Region
6.1 By Region - Global Recombinant Activated Coagulation Factor VII Market Size, 2022 & 2030
6.2 By Region - Global Recombinant Activated Coagulation Factor VII Revenue & Forecasts
6.2.1 By Region - Global Recombinant Activated Coagulation Factor VII Revenue, 2018-2023
6.2.2 By Region - Global Recombinant Activated Coagulation Factor VII Revenue, 2023-2030
6.2.3 By Region - Global Recombinant Activated Coagulation Factor VII Revenue Market Share, 2018-2030
6.3 By Region - Global Recombinant Activated Coagulation Factor VII Sales & Forecasts
6.3.1 By Region - Global Recombinant Activated Coagulation Factor VII Sales, 2018-2023
6.3.2 By Region - Global Recombinant Activated Coagulation Factor VII Sales, 2023-2030
6.3.3 By Region - Global Recombinant Activated Coagulation Factor VII Sales Market Share, 2018-2030
6.4 North America
6.4.1 By Country - North America Recombinant Activated Coagulation Factor VII Revenue, 2018-2030
6.4.2 By Country - North America Recombinant Activated Coagulation Factor VII Sales, 2018-2030
6.4.3 US Recombinant Activated Coagulation Factor VII Market Size, 2018-2030
6.4.4 Canada Recombinant Activated Coagulation Factor VII Market Size, 2018-2030
6.4.5 Mexico Recombinant Activated Coagulation Factor VII Market Size, 2018-2030
6.5 Europe
6.5.1 By Country - Europe Recombinant Activated Coagulation Factor VII Revenue, 2018-2030
6.5.2 By Country - Europe Recombinant Activated Coagulation Factor VII Sales, 2018-2030
6.5.3 Germany Recombinant Activated Coagulation Factor VII Market Size, 2018-2030
6.5.4 France Recombinant Activated Coagulation Factor VII Market Size, 2018-2030
6.5.5 U.K. Recombinant Activated Coagulation Factor VII Market Size, 2018-2030
6.5.6 Italy Recombinant Activated Coagulation Factor VII Market Size, 2018-2030
6.5.7 Russia Recombinant Activated Coagulation Factor VII Market Size, 2018-2030
6.5.8 Nordic Countries Recombinant Activated Coagulation Factor VII Market Size, 2018-2030
6.5.9 Benelux Recombinant Activated Coagulation Factor VII Market Size, 2018-2030
6.6 Asia
6.6.1 By Region - Asia Recombinant Activated Coagulation Factor VII Revenue, 2018-2030
6.6.2 By Region - Asia Recombinant Activated Coagulation Factor VII Sales, 2018-2030
6.6.3 China Recombinant Activated Coagulation Factor VII Market Size, 2018-2030
6.6.4 Japan Recombinant Activated Coagulation Factor VII Market Size, 2018-2030
6.6.5 South Korea Recombinant Activated Coagulation Factor VII Market Size, 2018-2030
6.6.6 Southeast Asia Recombinant Activated Coagulation Factor VII Market Size, 2018-2030
6.6.7 India Recombinant Activated Coagulation Factor VII Market Size, 2018-2030
6.7 South America
6.7.1 By Country - South America Recombinant Activated Coagulation Factor VII Revenue, 2018-2030
6.7.2 By Country - South America Recombinant Activated Coagulation Factor VII Sales, 2018-2030
6.7.3 Brazil Recombinant Activated Coagulation Factor VII Market Size, 2018-2030
6.7.4 Argentina Recombinant Activated Coagulation Factor VII Market Size, 2018-2030
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Recombinant Activated Coagulation Factor VII Revenue, 2018-2030
6.8.2 By Country - Middle East & Africa Recombinant Activated Coagulation Factor VII Sales, 2018-2030
6.8.3 Turkey Recombinant Activated Coagulation Factor VII Market Size, 2018-2030
6.8.4 Israel Recombinant Activated Coagulation Factor VII Market Size, 2018-2030
6.8.5 Saudi Arabia Recombinant Activated Coagulation Factor VII Market Size, 2018-2030
6.8.6 UAE Recombinant Activated Coagulation Factor VII Market Size, 2018-2030
7 Manufacturers & Brands Profiles
7.1 Novo Nordisk
7.1.1 Novo Nordisk Corporate Summary
7.1.2 Novo Nordisk Business Overview
7.1.3 Novo Nordisk Recombinant Activated Coagulation Factor VII Major Product Offerings
7.1.4 Novo Nordisk Recombinant Activated Coagulation Factor VII Sales and Revenue in Global (2018-2023)
7.1.5 Novo Nordisk Key News
7.2 LFB SA HEMA Biologics
7.2.1 LFB SA HEMA Biologics Corporate Summary
7.2.2 LFB SA HEMA Biologics Business Overview
7.2.3 LFB SA HEMA Biologics Recombinant Activated Coagulation Factor VII Major Product Offerings
7.2.4 LFB SA HEMA Biologics Recombinant Activated Coagulation Factor VII Sales and Revenue in Global (2018-2023)
7.2.5 LFB SA HEMA Biologics Key News
7.3 AryoGen Pharmed
7.3.1 AryoGen Pharmed Corporate Summary
7.3.2 AryoGen Pharmed Business Overview
7.3.3 AryoGen Pharmed Recombinant Activated Coagulation Factor VII Major Product Offerings
7.3.4 AryoGen Pharmed Recombinant Activated Coagulation Factor VII Sales and Revenue in Global (2018-2023)
7.3.5 AryoGen Pharmed Key News
8 Global Recombinant Activated Coagulation Factor VII Production Capacity, Analysis
8.1 Global Recombinant Activated Coagulation Factor VII Production Capacity, 2018-2030
8.2 Recombinant Activated Coagulation Factor VII Production Capacity of Key Manufacturers in Global Market
8.3 Global Recombinant Activated Coagulation Factor VII Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Recombinant Activated Coagulation Factor VII Supply Chain Analysis
10.1 Recombinant Activated Coagulation Factor VII Industry Value Chain
10.2 Recombinant Activated Coagulation Factor VII Upstream Market
10.3 Recombinant Activated Coagulation Factor VII Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Recombinant Activated Coagulation Factor VII Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Recombinant Activated Coagulation Factor VII in Global Market
Table 2. Top Recombinant Activated Coagulation Factor VII Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Recombinant Activated Coagulation Factor VII Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Recombinant Activated Coagulation Factor VII Revenue Share by Companies, 2018-2023
Table 5. Global Recombinant Activated Coagulation Factor VII Sales by Companies, (Units), 2018-2023
Table 6. Global Recombinant Activated Coagulation Factor VII Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Recombinant Activated Coagulation Factor VII Price (2018-2023) & (US$/Unit)
Table 8. Global Manufacturers Recombinant Activated Coagulation Factor VII Product Type
Table 9. List of Global Tier 1 Recombinant Activated Coagulation Factor VII Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Recombinant Activated Coagulation Factor VII Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Recombinant Activated Coagulation Factor VII Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Global Recombinant Activated Coagulation Factor VII Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Recombinant Activated Coagulation Factor VII Revenue (US$, Mn), 2023-2030
Table 14. By Type - Global Recombinant Activated Coagulation Factor VII Sales (Units), 2018-2023
Table 15. By Type - Global Recombinant Activated Coagulation Factor VII Sales (Units), 2023-2030
Table 16. By Application ? Global Recombinant Activated Coagulation Factor VII Revenue, (US$, Mn), 2022 & 2030
Table 17. By Application - Global Recombinant Activated Coagulation Factor VII Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Recombinant Activated Coagulation Factor VII Revenue (US$, Mn), 2023-2030
Table 19. By Application - Global Recombinant Activated Coagulation Factor VII Sales (Units), 2018-2023
Table 20. By Application - Global Recombinant Activated Coagulation Factor VII Sales (Units), 2023-2030
Table 21. By Region ? Global Recombinant Activated Coagulation Factor VII Revenue, (US$, Mn), 2022 VS 2030
Table 22. By Region - Global Recombinant Activated Coagulation Factor VII Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Recombinant Activated Coagulation Factor VII Revenue (US$, Mn), 2023-2030
Table 24. By Region - Global Recombinant Activated Coagulation Factor VII Sales (Units), 2018-2023
Table 25. By Region - Global Recombinant Activated Coagulation Factor VII Sales (Units), 2023-2030
Table 26. By Country - North America Recombinant Activated Coagulation Factor VII Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Recombinant Activated Coagulation Factor VII Revenue, (US$, Mn), 2023-2030
Table 28. By Country - North America Recombinant Activated Coagulation Factor VII Sales, (Units), 2018-2023
Table 29. By Country - North America Recombinant Activated Coagulation Factor VII Sales, (Units), 2023-2030
Table 30. By Country - Europe Recombinant Activated Coagulation Factor VII Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Recombinant Activated Coagulation Factor VII Revenue, (US$, Mn), 2023-2030
Table 32. By Country - Europe Recombinant Activated Coagulation Factor VII Sales, (Units), 2018-2023
Table 33. By Country - Europe Recombinant Activated Coagulation Factor VII Sales, (Units), 2023-2030
Table 34. By Region - Asia Recombinant Activated Coagulation Factor VII Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Recombinant Activated Coagulation Factor VII Revenue, (US$, Mn), 2023-2030
Table 36. By Region - Asia Recombinant Activated Coagulation Factor VII Sales, (Units), 2018-2023
Table 37. By Region - Asia Recombinant Activated Coagulation Factor VII Sales, (Units), 2023-2030
Table 38. By Country - South America Recombinant Activated Coagulation Factor VII Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Recombinant Activated Coagulation Factor VII Revenue, (US$, Mn), 2023-2030
Table 40. By Country - South America Recombinant Activated Coagulation Factor VII Sales, (Units), 2018-2023
Table 41. By Country - South America Recombinant Activated Coagulation Factor VII Sales, (Units), 2023-2030
Table 42. By Country - Middle East & Africa Recombinant Activated Coagulation Factor VII Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Recombinant Activated Coagulation Factor VII Revenue, (US$, Mn), 2023-2030
Table 44. By Country - Middle East & Africa Recombinant Activated Coagulation Factor VII Sales, (Units), 2018-2023
Table 45. By Country - Middle East & Africa Recombinant Activated Coagulation Factor VII Sales, (Units), 2023-2030
Table 46. Novo Nordisk Corporate Summary
Table 47. Novo Nordisk Recombinant Activated Coagulation Factor VII Product Offerings
Table 48. Novo Nordisk Recombinant Activated Coagulation Factor VII Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 49. LFB SA HEMA Biologics Corporate Summary
Table 50. LFB SA HEMA Biologics Recombinant Activated Coagulation Factor VII Product Offerings
Table 51. LFB SA HEMA Biologics Recombinant Activated Coagulation Factor VII Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 52. AryoGen Pharmed Corporate Summary
Table 53. AryoGen Pharmed Recombinant Activated Coagulation Factor VII Product Offerings
Table 54. AryoGen Pharmed Recombinant Activated Coagulation Factor VII Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 55. Recombinant Activated Coagulation Factor VII Production Capacity (Units) of Key Manufacturers in Global Market, 2020-2023 (Units)
Table 56. Global Recombinant Activated Coagulation Factor VII Capacity Market Share of Key Manufacturers, 2020-2023
Table 57. Global Recombinant Activated Coagulation Factor VII Production by Region, 2018-2023 (Units)
Table 58. Global Recombinant Activated Coagulation Factor VII Production by Region, 2023-2030 (Units)
Table 59. Recombinant Activated Coagulation Factor VII Market Opportunities & Trends in Global Market
Table 60. Recombinant Activated Coagulation Factor VII Market Drivers in Global Market
Table 61. Recombinant Activated Coagulation Factor VII Market Restraints in Global Market
Table 62. Recombinant Activated Coagulation Factor VII Raw Materials
Table 63. Recombinant Activated Coagulation Factor VII Raw Materials Suppliers in Global Market
Table 64. Typical Recombinant Activated Coagulation Factor VII Downstream
Table 65. Recombinant Activated Coagulation Factor VII Downstream Clients in Global Market
Table 66. Recombinant Activated Coagulation Factor VII Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Recombinant Activated Coagulation Factor VII Segment by Type
Figure 2. Recombinant Activated Coagulation Factor VII Segment by Application
Figure 3. Global Recombinant Activated Coagulation Factor VII Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Recombinant Activated Coagulation Factor VII Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Recombinant Activated Coagulation Factor VII Revenue, 2018-2030 (US$, Mn)
Figure 7. Recombinant Activated Coagulation Factor VII Sales in Global Market: 2018-2030 (Units)
Figure 8. The Top 3 and 5 Players Market Share by Recombinant Activated Coagulation Factor VII Revenue in 2022
Figure 9. By Type - Global Recombinant Activated Coagulation Factor VII Sales Market Share, 2018-2030
Figure 10. By Type - Global Recombinant Activated Coagulation Factor VII Revenue Market Share, 2018-2030
Figure 11. By Type - Global Recombinant Activated Coagulation Factor VII Price (US$/Unit), 2018-2030
Figure 12. By Application - Global Recombinant Activated Coagulation Factor VII Sales Market Share, 2018-2030
Figure 13. By Application - Global Recombinant Activated Coagulation Factor VII Revenue Market Share, 2018-2030
Figure 14. By Application - Global Recombinant Activated Coagulation Factor VII Price (US$/Unit), 2018-2030
Figure 15. By Region - Global Recombinant Activated Coagulation Factor VII Sales Market Share, 2018-2030
Figure 16. By Region - Global Recombinant Activated Coagulation Factor VII Revenue Market Share, 2018-2030
Figure 17. By Country - North America Recombinant Activated Coagulation Factor VII Revenue Market Share, 2018-2030
Figure 18. By Country - North America Recombinant Activated Coagulation Factor VII Sales Market Share, 2018-2030
Figure 19. US Recombinant Activated Coagulation Factor VII Revenue, (US$, Mn), 2018-2030
Figure 20. Canada Recombinant Activated Coagulation Factor VII Revenue, (US$, Mn), 2018-2030
Figure 21. Mexico Recombinant Activated Coagulation Factor VII Revenue, (US$, Mn), 2018-2030
Figure 22. By Country - Europe Recombinant Activated Coagulation Factor VII Revenue Market Share, 2018-2030
Figure 23. By Country - Europe Recombinant Activated Coagulation Factor VII Sales Market Share, 2018-2030
Figure 24. Germany Recombinant Activated Coagulation Factor VII Revenue, (US$, Mn), 2018-2030
Figure 25. France Recombinant Activated Coagulation Factor VII Revenue, (US$, Mn), 2018-2030
Figure 26. U.K. Recombinant Activated Coagulation Factor VII Revenue, (US$, Mn), 2018-2030
Figure 27. Italy Recombinant Activated Coagulation Factor VII Revenue, (US$, Mn), 2018-2030
Figure 28. Russia Recombinant Activated Coagulation Factor VII Revenue, (US$, Mn), 2018-2030
Figure 29. Nordic Countries Recombinant Activated Coagulation Factor VII Revenue, (US$, Mn), 2018-2030
Figure 30. Benelux Recombinant Activated Coagulation Factor VII Revenue, (US$, Mn), 2018-2030
Figure 31. By Region - Asia Recombinant Activated Coagulation Factor VII Revenue Market Share, 2018-2030
Figure 32. By Region - Asia Recombinant Activated Coagulation Factor VII Sales Market Share, 2018-2030
Figure 33. China Recombinant Activated Coagulation Factor VII Revenue, (US$, Mn), 2018-2030
Figure 34. Japan Recombinant Activated Coagulation Factor VII Revenue, (US$, Mn), 2018-2030
Figure 35. South Korea Recombinant Activated Coagulation Factor VII Revenue, (US$, Mn), 2018-2030
Figure 36. Southeast Asia Recombinant Activated Coagulation Factor VII Revenue, (US$, Mn), 2018-2030
Figure 37. India Recombinant Activated Coagulation Factor VII Revenue, (US$, Mn), 2018-2030
Figure 38. By Country - South America Recombinant Activated Coagulation Factor VII Revenue Market Share, 2018-2030
Figure 39. By Country - South America Recombinant Activated Coagulation Factor VII Sales Market Share, 2018-2030
Figure 40. Brazil Recombinant Activated Coagulation Factor VII Revenue, (US$, Mn), 2018-2030
Figure 41. Argentina Recombinant Activated Coagulation Factor VII Revenue, (US$, Mn), 2018-2030
Figure 42. By Country - Middle East & Africa Recombinant Activated Coagulation Factor VII Revenue Market Share, 2018-2030
Figure 43. By Country - Middle East & Africa Recombinant Activated Coagulation Factor VII Sales Market Share, 2018-2030
Figure 44. Turkey Recombinant Activated Coagulation Factor VII Revenue, (US$, Mn), 2018-2030
Figure 45. Israel Recombinant Activated Coagulation Factor VII Revenue, (US$, Mn), 2018-2030
Figure 46. Saudi Arabia Recombinant Activated Coagulation Factor VII Revenue, (US$, Mn), 2018-2030
Figure 47. UAE Recombinant Activated Coagulation Factor VII Revenue, (US$, Mn), 2018-2030
Figure 48. Global Recombinant Activated Coagulation Factor VII Production Capacity (Units), 2018-2030
Figure 49. The Percentage of Production Recombinant Activated Coagulation Factor VII by Region, 2022 VS 2030
Figure 50. Recombinant Activated Coagulation Factor VII Industry Value Chain
Figure 51. Marketing Channels
